PCV13, also known as Prevnar 13, was approved by the FDA in 2010 for children and 2011 for adults. ... You may receive a pneumococcal vaccine at the same time as a flu vaccine.

Pneumococcal vaccine for babies and young children. PCV15 and PCV20 are safe for children under 5, with doses given at 2 months, 4 months, 6 months, and 12-15 months.

Dominance of the pneumococcal vaccine category is a race between Merck & Co and Pfizer, and while the latter is comfortably in front at the moment with its Prevnar franchise, Merck has multiple ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD.

Vaxcyte unveiled what analysts called “stunning” phase 1/2 data for its 31-valent pneumococcal vaccine candidate that, ... could pose a serious threat to Pfizer’s stalwart Prevnar 20. ...

A press release from the Medical Research Council-The Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM) on Tuesday, June 24, 2025, stated that the World Health Organisation ...

Each year, the U.S. sees roughly 30,000 cases of invasive pneumococcal disease, which includes blood infections, brain and spine inflammation, pneumonia, meningitis and other illnesses.

People 50 and Older Should Get Pneumococcal Vaccine, U.S. Health Officials Recommend NEW YORK (AP) — U.S. health officials on Wednesday recommended that people 50 and older get a shot against ...

The first pneumococcal vaccine was licensed in the U.S. in 1977, and since then pharmaceutical companies have been coming up with newer versions that target a dozen or more types in a single shot.